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Characterization o f  human lymphocyte N-acetyltransferase ( N A T ) f o r  
specific activity, substrate specificity, inhibition, pH optimum, apparent Kin, 
kinetic mechanism, trypsin stability, freezing stability, and heat stability 
was carried out in rapid and slow isoniazid (INH) acetylators. There is a 
statistically significant difference in the heat stability o f  lymphocyte N A T  
from rapid and slow INH phenotypes. The lymphocyte enzyme from rapid 
INH acetylators is less heat stable than the lymphocyte enzyme from slow 
INH acetylators. This is an indication o f  a structural, possibly polymorphic, 
difference in lymphocyte N A T  from the two acetylator phenotypes. 
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INTRODUCTION 
Acetylation is an important metabolic route for inactivation of drugs and 
carcinogens that are arylamines or hydrazine derivatives. The reaction, 
catalyzed by N-acetyltransferases (NAT), involves the transfer of the acetyl 
group from acetyl coenzyme A (AcCoA) to the arylamine substrate (Lip- 
mann, 1945). Individuals are classified as rapid or slow acetylators according 
to the rate at which drugs such as isoniazid (INH) or sulfamethazine (SMZ) 
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are acetylated by liver NAT (Knight et al., 1959; Evans et al., 1960). The 
slow acetylator phenotype is homozygous recessive while the rapid aeetylator 
phenotype is heterozygous or homozygous dominant. Both man and the rabbit 
possess this INH acetylator polymorphism (Knight et al., 1959; Evans et al., 
1960; Frymoyer and Jacox, 1963; Gordon et al., 1973). 
An extrahepatic polymorphism has also been described in the rabbit that 
involves the acetylation of p-aminobenzoic acid (PABA) and is related to the 
INH phenotype (Weber et al., 1975, 1976; Szabadi et al., 1978). Rapid INH 
acetylator animals have low blood PABA NAT while the slow phenotype has 
high blood PABA NAT. This relationship is also seen in lymphocytes as well 
as red blood cells (Weber et al., 1976). 
Although previous studies have failed to detect any relationship between 
extrahepatic NAT and the INH phenotype in man, activity has been the only 
criterion used (Motulsky and Steinmann, 1962; Drayer et al., 1974; Hearse et 
al., 1970). Alterations in the enzyme could affect any of its biochemical 
properties (Paigen, 1971). This study was undertaken to determine whether 
there are differences in the genetic and biochemical characteristics of human 
lymphocyte NAT that are associated with different INH acetylator pheno- 
types. 
MATERIALS AND METHODS 
Determination of Acetylator Phenotype 
Individuals were phenotyped as rapid or slow INH acetylators by a slight 
modification of the method of Evans (1969). Blood and urine samples were 
obtained from healthy adult volunteers who had not eaten for 2 hr prior to the 
test. SMZ (10 mg/kg) was given oI'ally, and blood and urine samples were 
collected 41/2 hr later. The percent of acetylated drug was then determined 
(Weber and Brenner, 1974). 
Separation of Peripheral Lymphocytes 
The method developed by B6yum (1967) and modified by Lopes et al. (1973) 
was used to separate lymphocytes from peripheral blood samples. The 
gradient mixture was prepared by combining 2.4 parts of 9% Ficoll 400 (9 
g/100 ml 1 × 10 -2 Tris-HCl, pH 7.4) with 1 part Hypaque mixture (45.3 ml 
Hypaque-M75, 1 ml of 1 M Tris-HC1, pH 7.4, and 53.7 ml H20). The blood 
sample was diluted 1:1 with phosphate-buffered saline (PBS), pH 7.4, 
layered on the gradient mixture (ratio of sample to gradient mixture is 2:1) 
and centrifuged for 30 min in a GLC II (Sorvall, Norwalk, Connecticut) at 
400g. After the mononuclear layer had been washed, the cells were counted, 
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divided into aliquots, and centrifuged for 10 lnin at 1300g in a GLC II. The 
supernatant was removed and the cell pellet stored at - 7 0 C  in an ultrafreez- 
or .  
Assay for PABA NAT Activity 
Samples were assayed for enzyme activity using a spectrophotometric micro- 
assay system (Hearse and Weber, 1973). A cell pellet was resuspended in 0.1 
M phosphate buffer, pH 7.0, with 10 -3 M dithiothreitol (DTT) and 10 -3 M 
ethylenediamine tetraacetic acid (EDTA) to give a concentration of approxi- 
mately 10 x 10 6 cells/ml. This suspension was subjected to eight to ten 
rounds of freezing in a dry ice and methanol bath and thawing in a 37C water 
bath in order to lyse the cells. Fifty microliters of the lysate was used to 
determine enzyme activity. 
Culture of Human Peripheral Lymphoeytes 
Lymphocytes were maintained in culture according to the method of Bloom 
and Iida (1967). The cell culture medium was prepared by adding fetal calf 
serum (10% v/v), penicillin (50 units/ml), and streptomycin (50 #g/ml) to 
RPMI 1640, minus PABA (Flow Laboratories, Rockville, Maryland). 
Isolated lymphocytes were added to the medium to give a concentration of 
approximately 5 x 105 cells/ml. Ten milliliters of the cell and medium 
suspension was pipetted into a T25 flask with 0.1 ml of phytohemagglutinin 
(Burroughs Wellcome, Research Triangle Park, North Carolina) and incu- 
bated at 37C in a 5% CO2 atmosphere. 
Protein Determinations 
The amount of protein in a cell lysate was determined by a microbiuret 
reaction (Gornall et al., 1949). 
Experimental Conditions for Comparative Determinations 
of Lymphocytes NAT from Rapid and Slow INH Acetylators 
Substrate  Specificity 
All compounds were assayed for substrate potential for lymphocyte NAT by 
the procedure described for determination of PABA NAT activity. The final 
concentration of substrate was 4.4. × 10 5M in all cases. 
Inhibition 
Cell pellets were resuspended with 0.1 M potassium phosphate buffer, pH 7.0, 
to a concentration of approximately 20 x 10 6 cells/ml and lysed by freezing 
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and thawing as previously described. Twenty-five microliters of the cell lysate 
was used in the enzyme assay. The test compound (25 #1) at the appropriate 
concentration was added to the incubation mixture and the procedure 
followed as previously described. 
pH Optimum 
pH optimum curves were determined in 0.1 M potassium pyrophosphate 
buffer adjusted to the desired pH with HC1. Cell samples, isolated from a 
single individual, were each resuspended to a final concentration of 10 x l 0  6 
cells/ml in buffer at several specific pH's, and lysed by repeated freezing and 
thawing. Enzyme activity was determined as previously described. 
Stability to Freezing 
The cell lysate was divided into aliquots and stored at - 20C. Enzyme activity 
was determined on a freshly thawed sample at specified time intervals. 
Trypsin Inactivation 
The cell pellet was resuspended in 0.1 M phosphate buffer, pH 7.0, with 10 3 
M DTT and 10 -3 EDTA to a concentration of approximately 17 x l 0  6 
cells/ml. Thirty microliters of the cell lysate was added to a 400-#1 tube, and 
a 10-#1 aliquot of 0.01% trypsin solution (Worthington Biochemical Corp., 
Freehold, New Jersey) was then added. The mixture was incubated in a 33C 
water bath for specified times, and the action of the trypsin was stopped by 
the addition of 10 #1 of 0.01% soybean trypsin inhibitor (Worthington 
Biochemical Corp., Freehold, New Jersey). The samples were then assayed 
for residual PABA NAT activity by the procedure previously described. 
Stability to Heat 
Fifty-microliter aliquots of the cell lysate (10 × 10 6 cells/ml) were placed in 
400-#1 tubes. The samples were then placed in an Aquatherm water bath 
(New Brunswick Scientific Co., New Brunswick, New Jersey) at 44C, heated 
for a specified time, removed, and placed on ice. Blanks and zero-time 
samples were kept on ice and then assayed with the experimental samples for 
PABA NAT activity by the assay previously described. 
RESULTS 
Healthy adult volunteers were phenotyped as rapid or slow acetylators of 
SMZ by determining the percent of acetylated drug in blood and urine 
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(Evans, 1969; Weber and Brenner, 1974). Slow acetylators had less than 75% 
acetylated drug in urine and 40% in blood, while rapid acetylators had greater 
than 80% in urine and 45% in blood. 
Differential cell counts were done on the mononuclear layer obtained in 
the Ficoll Hypaque gradient, and almost equal numbers of lymphocytes and 
monocytes were present. After this fraction had been washed, almost 90% of 
the monocytes were removed, so the final preparation contained appproxi- 
mately 6% monocytes. NAT activity was sought in a purified preparation of 
monocytes and none was detected. Therefore, the monocyte contribution to 
PABA NAT activity in the mononuclear cell fraction was negligible. 
The biochemical characteristics of lymphocyte NAT from rapid and 
slow INH acetylators were determined. Comparisons of specific activity, 
substrate specificity, kinetic properties, inhibitors, pH optimum, and stability 
were made. 
Table I. Specific Activity of Lymphocyte PABA N A T  from Rapid and Slow INH Acetylators 
Rapid IN H acetylators Slow INH acetylators 
Donor nmol A c P A B A / h r / m g  Donor nmol A c P A B A / h r / m g  
ML 105 
AA 114 
PS 116 
SL 119 
LB 120 
IG 131 
VZ 134 
SB 136 
WB 141 
PN 142 
DK 146 
HE 150 
MV 169 
JB 171 
DR 178 
M E A N  138 
SD 22 
N 15 
BW 106 
EP 108 
GG 113 
CAS 113 
R T  121 
LH 124 
CS 127 
FC 130 
WV 136 
CM 144 
KL 145 
JS 148 
DG 149 
SH 152 
CH 158 
HR  158 
KM  170 
BB 172 
PDS 172 
OL 173 
DH 174 
M A L  207 
W W  215 
RV 225 
151 
32 
24 
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Specific Activity 
The activity of lymphocyte N A T  (nmol acetyl p-aminobenzoic acid (AcPA- 
BA) fo rmed /h r /mg  protein) was determined for both I N H  acetylator pheno- 
types. The range of N A T  activity in the slow phenotype was 106-225 and was 
105-178 in the rapid phenotype (Table I). No relationship was observed 
between the specific activity of N A T  in the lymphocyte and the acetylator 
phenotype. 
Substrate Specificity 
The ability of lymphocyte N A T  to acetylate SMZ,  benzocaine, and procain- 
amide as well as PABA was tested. PABA was the only acetyl acceptor found. 
N A T  activity for SMZ,  benzocaine, or procainamide was not detected in 
either acetylator phenotype. 
Kinetic Properties 
Initial velocities were determined for PABA and AcCoA using lymphocytes 
from six individuals of both acetylator phenotypes and graphed as double 
reciprocal (Lineweaver-Burk) plots. No differences were detected in the Km 
or Vmax values obtained from each acetylator phenotype. Average Km values of 
1.71 x 10 -4 M and 1.82 x 10 4 M were obtained for PABA and AcCoA, 
respectively, while average Vmax values of 574 and 199 nmol A c P A B A / h r / m g  
protein were obtained for PABA and AcCoA, respectively. The kinetic 
constants for PABA were determined at an AcCoA concentration of 2.43 x 
10 -3 M while the kinetic constants for AcCoA were determined at a PABA 
concentration of 4.4 x 10 -5 M. A series of initial velocity curves was run 
varying both substrates and yielded a series of parallel lines. 
Innhibitors 
Various metal ions were tested for their effect on lymphocyte N A T  activity. 
The  metal concentrations ranged from 10 -3 M to 10 -7 M. Fe 3+, Mn 2+, C a  2+, 
and Fe 2+ had no effect on enzyme activity, but 50% inhibition was seen at 
10 -5 M Cu 2+, 1.4 x 10 4 M Zn 2+, and 5.5 x 10 -6 M Hg 2+. N-Ethylmaleimide, 
a sulfhydryl group inhibitor, was a potent inhibitor of the enzyme with a 
concentration of 1 x 10 -6 M resulting in a 50% loss of activity. The products 
of  the enzyme reaction, coenzyme A and AcPABA, were poor inhibitors. The 
addition of 10 -3 M AcPABA resulted in a 60% loss of enzyme activity and of 
10 -3 M CoA an 18% loss. No activation of the enzyme was seen. The effects of 
all the compoundstested were the same for both acetylator phenotypes. 
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Fig. 1. Activity at pH 5.0-9.0 of lymphocyte NAT from rapid (e) and slow (I )  acetylators. The 
cells were lysed in 0.1 M pyrophosphate buffer of varying pH's and assayed for enzyme activity 
according to the procedure in Materials and Methods. 
pH optimum 
pH optimum curves were determined for human lymphocyte PABA NAT 
from rapid and slow INH acetylators. A pH range of 5.0-9.0 (0.5 pH unit 
intervals) was used initially and both phenotypes had a peak of activity at pH 
7.0 (Fig. 1). When a pH range of 6.2-7.8 (0.2 pH unit intervals) was used, 
the peak of activity was found to be broader, approximately 6.6-7.4. No 
significant differences were found between the pH curves from the two 
acetylator phenotypes. 
Stability 
The stability of lymphocyte PABA NAT to a variety of agents and conditions 
was tested. Lymphocyte lysates from both acetylator phenotypes were stored 
at - 20C, then assayed for NAT activity. No differences were observed in the 
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s tabi l i ty  of act ivi ty  dur ing the first 18 days,  and an average of 60% of the 
ac t iv i ty  was still de tec tab le  between 21 and 72 days.  Pr ior  addi t ion  of  A c C o A  
2.85 x 10 -3 M) to the lysate did  not exert  a protect ive effect agains t  s torage at  
- 20C. 
T rea tmen t  of lymphocyte  N A T  from six individuals,  three  rapid  and 
th ree  slow acetylators ,  with 0.01% trypsin for varying t ime periods resul ted in 
a 50% loss of  act ivi ty  in 13-22 min. The  average tl/2 for the slow acetyla tors  
was 17 min, the same average  obta ined  for the rapid  phenotype.  
The  effect of  heat ing on lymphocyte  N A T  was ini t ial ly de te rmined  at  
t e m p e r a t u r e s  ranging f rom 30 to 53C for 5 min. A t  t empera tu res  less than  
40C,  at  least  90% of the enzyme act ivi ty  was still present  af ter  5 min of  
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Fig. 2. Inactivation of lymphocyte NAT at 44C. The cell lysate was heated at 44C for 0, 4, 8, 12, 
and 16 min, then placed on ice. Enzyme activity was determined according to the procedure in 
Materials and Methods. The log of the product was plotted against the time at 44C. The tl/2 and 
k were determined by regression analysis. Rapid INH acetylator (O) tll2 = 15 min, k = 0.048 
min -t, r = 0.99; slow INH acetylator (I)  tl/~ = 8.3 min, k = 0.083 min -1, r = 0.97. 
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Table II. Inactivation at 44 C of Lymphocyte N A T  from Rapid and Slow INH Acetylators 
Slow INH acetylators Rapid INH acetylators 
Donor k(min -~ ) tu2(min ) Donor k(min -~ ) tu2(min) 
GG 0.034 21 
BB 0.037 19 
CH 0.043 16 
W W  0.044 16 
RT 0.046 15 
CS 0.048 15 
RV 0.048 15 
OL 0.049 15 
BW 0.050 14 
HR 0.051 14 
DG 0.053 13 
FC 0.056 12 
PDS 0.056 12 
DW 0.057 12 
LH 0.058 12 
KM 0.058 12 
WV 0.061 12 
EP 0.061 12 
DH 0.065 11 
KL 0.066 10 
JS 0.070 10 
CM 0.071 10 
M A L  0.076 9.2 
CAS 0. I O7 6.6 
Mean 0.056 13 
so  0.015 3.2 
N 24 24 
VZ 0.048 15 
SL 0.057 12 
AA 0.058 12 
LB 0.061 11 
DK 0.066 11 
SB 0.072 10 
DR 0.073 10 
PN 0.078 8.8 
IG 0.081 8.7 
PS 0.081 8.6 
SH 0.089 8.1 
HE 0.091 8.0 
ML 0.106 6.6 
WB 0.110 6.6 
JB 0.183 3.8 
0.084 9 
0.033 2.7 
15 15 
heating, while at 46C, only 20% of the enzyme activity remained. Subse- 
quently, the stability of the enzyme was determined at 44C. Lymphoeytes 
from 39 healthy adult volunteers, 17 females and 22 males, were used. 
Semilog plots of NAT activity vs. time of heating yielded straight lines (Fig. 
2). The rate of inactivation (k rain -1) and the half-life (tl/2 min) were 
calculated using a semilog regression program. Lymphocyte PABA NAT 
from rapid acetylators was more sensitive to heating than enzyme from slow 
acetylators. The mean ti/2 value from rapid acetylators was 9 rain (k = 0.084 
min -1) and for slow aeetylators was 13 min (k= 0.056 min -l) (Table II and 
Fig. 3). This difference was statistically significant (p < 0.001) in a Student's 
t test. 
The reproducibility of the tl/2 was tested in the same cell sample and in 
different cell samples from the same individual. A ratio of the lowest tl/2 to 
the highest tu2 was calculated for each individual. The average ratio for 
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Fig. 3. Distribution of the half-life (tU2) at 44C of lymphocyte NAT in rapid and slow INH 
acetylators. 
multiple determinations using the same cell sample was 0.83 and for different 
cell samples obtained from the same individual it was 0.76. This indicates 
that the variation seen in repeated h/2 determinations on an individual were 
not due to changes in the cell population of the blood sample. 
The t~/2 in either phenotype was not effected by dialysis of the cell lysate 
against 0.1 M potassium phosphate, pH 7.0, plus 10 -3 M DTT plus 10 -3 M 
EDTA before the tl/2 determination. Lysing the cells in buffer with or without 
10  -3 M DTT and/or  10 -3 M EDTA did not alter the heat inactivation curves. 
The lymphocyte lysate from a rapid acetylator was mixed with lysate 
from a slow acetylator, and the tl/2 and k at 44C were determined. The k 
value of 0.059 min -1 obtained was approximately the average of the values 
for the two phenotypes, 0.045 min -~ for the slow acetylator and 0.069 rain -x 
for the rapid acetylator. The tl/2 of the mixture was 12 min, with values of 15 
min for the slow acetylator and 11 min for the rapid acetylator. 
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Table l l I .  Effect of Compounds on the Stability of Lymphocyte NAT at 44 C 
Rapid INH Slow INH 
acetylator acetylator 
q/z(min) q/2(min) 
M B B 
Compound concentration A B A A B 
AcCoA 2.86 x 10 -3 14 - -  - -  12 153 13 
AcCoA 2.86 x 10 -4 14 206 15 12 123 10 
AcCoA 2.86 x 10 -5 14 134 10 12 127 11 
AcCoA 2.86 x 10 -6 14 221 16 12 91 8 
AcCoA 2.86 × 10 -7 14 38 3 12 18 2 
A c l N H  1.30 × 10 -3 7 7 1 11 13 1 
Acthiocholine 2.86 x 10 -4 11 12 1 15 20 1 
Actryptamine 2.86 x 10 -4 8 9 1 11 15 1 
INH 1.30 x 10 -3 7 15 2 11 29 3 
Melatonin 2.86 x 10 -4 8 10 1 12 10 1 
Nicotinamide 2.86 x 10 -4 11 8 1 15 12 1 
PABA 5.70 x 10 -4 7 31 5 11 23 2 
Serotonin 2.86 × 10 -4 8 13 2 15 21 1 
Tryptaminc 2.86 x 10 -4 8 8 1 11 11 1 
A variety of compounds were screened for their ability to stabilize 
lymphocyte N A T  against heat denaturation. The test compound was added to 
the cell lysate and heated at 44C, and the residual enzyme activity was 
determined. A ratio of the tU2 with the compound to the t~/2 of the enzyme 
alone was calculated. A value of 1 was expected if no stabilization occurred, 
with the greatest stabilization giving the highest value. AcCoA was the most 
effective compound (Table III) .  A concentration of approximately 3 × 10 -5 
M resulted in a tenfold increase in the tl/2; even a concentration of 3 × 10 -7 M 
had an appreciable effect. PABA and I N H  were less effective while acetyl- 
thiocholine, serotonin, nicotinamide, acetylisoniazid (AcINH) ,  melatonin, 
tryptamine, and acetyltrptamine had no effect. 
Cell Culture 
Cultures of fleshly isolated peripheral lymphocytes, stimulated with PHA, 
had PABA N A T  activity which peaked at 96-120 hr. The amount of activity 
was comparable to that in uncultured cells. 
The stability at 44C of cells cultured for 96 hr was tested and found to be 
the same as for uncultured cells. For a rapid acetylator, a t~/2 of 9 min 
k = 0.080 min -I)  was obtained after cell culture while the uncultured cells 
had a tu2 of 8 min (k = 0.082 min 1). The values seen for slow acetylators 
were 9 rain (k = 0.080 min -1) for the cultured cells as compared to 11 rain 
(k  = 0.065 min -1) for the uncultured cells. 
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DISCUSSION 
Rabbits exhibit a polymorphism in hepatic (Frymoyer and Jacox, 1963; 
Gordon et al., 1973) as well as extrahepatic NATs (Weber et al., 1975, 1976; 
Szabadi et al., 1978). The hepatic enzyme determines the rate of acetylation 
of drugs such as INH, and animals are designated as rapid or slow acetylators 
(Frymoyer and Jacox, 1963; Gordon et al., 1973). Blood NAT metabolizes 
PABA, and animals are designated as having high or low levels of activity 
(Weber et al., 1975, 1976). A relationship exists between these two polymor- 
phisms, with rapid INH acetylators having low blood PABA NAT activity 
and slow INH acetylators having high blood PABA NAT. Fractionation of 
rabbit blood cell samples shows that the difference in PABA NAT activity is 
present in the red cell and lymphocyte (Szabadi et al., 1978). 
Since rabbit and man both express the liver NAT polymorphism, it was 
reasonable to see if the extrahepatic polymorphism is present in man as well. 
Because polymorphic differences can be expressed in an alteration of activity, 
thermal stability, pH optimum, or any of the biochemical properties of an 
enzyme (Paigen, 1971), a variety of parameters of lymphocyte NAT were 
tested. The purposes of this study were to characterize human lymphocyte 
NAT of rapid and slow INH acetylators and to seek correlations between 
genetically determined INH acetylator phenotypes and one or more biochem- 
ical properties of lymphocyte NAT. A comparison of the properties of human 
lymphocyte NAT from the two acetylator phenotypes revealed no differences 
in the specific activity, substrate specificity, kinetic properties, inhibition, pH 
optimum, stability to trypsin, or stability to freezing. Heat stability studies 
did show that lymphocyte PABA NAT from human rapid acetylators was 
more sensitive to inactivation at 44C than enzyme from slow acetylators 
(Table II). 
The differential heat stabilities observed may be accounted for in several 
ways: 
1. By the presence of an inhibitor of PABA NAT. 
2. By the presence of a stabilizing agent of PABA NAT. 
3. By the posttranslational modification of the enzyme. 
4. By a structural gene difference. 
Results of mixing experiments and the similarities in specific activities of the 
enzyme from the two acetylator phenotypes argue against the first two 
possibilities. When lymphocyte NAT from a rapid INH acetylator was mixed 
with that from a slow acetylator, the k at 44C of the mixture was the average 
of the two phenotypes. If an inhibitor were present, the expected tl/2 or k 
would be like that of the less stable type, while if a stabilizing agent were 
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present, the value would be more like that of the more stable phenotype. The 
presence of a stabilizer or an inhibitor should also be reflected in the specific 
activity of lymphocyte NAT. The phenotype with the inhibitor would be 
expected to have a low specific activity while the phenotype with the stabilizer 
would have a high specific activity. No such differences were seen in the 
specific activity of human lymphocyte NAT in the rapid or slow INH 
phenotypes (Table I), although rabbit blood NAT did show differences in 
specific activity which, it has been postulated, may be due to a stabilizing 
agent inactivated by the polymorphic NAT. Greater amounts of this 
substance would be present in slow acetylators since they have a lower liver 
NAT activity than rapid acetylators (Szabadi et  al., 1978). The only 
substance that had a substantial effect on the heat stability of human 
lymphocyte NAT was the acetyl donor substrate of the reaction, AcCoA 
(Table III). A stable acetyl enzyme intermediate could be formed by the 
lymphocyte enzyme which seems to have the same kinetic mechanisms as the 
rabbit liver enzyme. Initial velocity studies of both rabbit liver NAT (Weber 
and Cohen, 1963; Weber et al., 1968) and human lymphocyte NAT showed a 
series of parallel lines. Differences in the concentration of AcCoA in rapid 
and slow acetylators, then, could effect the stability of the lymphocyte 
enzyme. Dialysis of the enzyme, however, did not change the stability of 
lymphocyte NAT, ruling out the presence of a dialyzable stabilizer, like 
AcCoA, or an inhibitor. 
The biochemical characteristics of an enzyme such as heat stability can 
be altered by posttranslational modifications of the enzyme. Studies of 
murine kidney catalase isolated from inbred strains C3H and C57B1/6 
indicated that they were electrophoretically different (Hoffman and Griesha- 
ber, 1976). Breeding studies done with these strains showed the electropho- 
retic pattern from the F1 generation to be identical to that of C57B1/6 
parent. If enzyme from the parental strains was mixed and then subjected to 
electrophoresis, the pattern of the C57B1/6 parent was seen. This suggests 
that some posttranslational modification had converted C3H type to the 
C57B1/6 type. 
A similar pattern of events was seen with human adenosine deaminase, 
where different tissues give different electrophoretic patterns. Mixing of 
homogenates from one tissue (e.g, RBCs) with another (e.g., kidney) was 
followed by electrophoresis which resulted in a single pattern (kidney) 
(Hirshhorn, 1975). 
Although it is possible that the differential heat stability seen in 
lymphocyte NAT could be due to a posttranslational modification, the results 
of mixing experiments previously described were not consistent with this. 
Electrophoresis, the technique used in the studies described above, was not 
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done with lymphocyte NAT because a staining technique for this enzyme is 
not available. 
The final explanation for the differential heat stability seen in human 
lymphocyte NAT is a structural gene difference. While evidence from this 
study is consistent with that hypothesis, further work is necessary to demon- 
strate the nature of the differences. The ultimate way to determine an 
alteration in a structural gene is amino acid sequencing, which requires a 
highly purified preparation of the enzyme. Even techniques such as peptide 
mapping that could detect amino acid differences require a more highly 
purified enzyme than is presently available. 
Studies with bovine carboxypeptidase A in which the amino acid 
sequences were determined do support the possibility of a structural gene 
difference accounting for differential heat stability. Two forms of the enzyme 
having the same specific activities were isolated from pancreatic tissue. One 
form of the enzyme had a tl/2 at 50C of about 25 rain and the other a value of 
about 50 min. Sequencing of the terminal peptide showed they differed only 
in the C-terminal amino acid. The more stable form of the enzyme contained 
valine, and the less stable form contained leucine (Walsh et al., 1966). 
A limited study was done to determine if the differential heat stability 
had a genetic component. Data obtained on three human families were 
consistent with the tl/2 and k of lymphocyte NAT being determined by a 
two-allele system, but more extensive family studies would be necessary to 
confirm this hypothesis. 
Among the several species of mammals which have been studied, a 
relationship is always observed between liver INH phenotype and extrahe- 
patic NAT, but the nature of this relationship varies from one species to 
another. Deer mice show a direct correlation between liver NAT activity and 
blood PABA NAT (Tanner and Weber, 1977). Rabbits, on the other hand, 
show an inverse relationship, which rapid INH acetylators having low levels 
of blood PABA NAT and slow INH acetylators having high blood PABA 
NAT activity (Weber et al., 1976; Szabadi et al., 1978). Biochemical studies 
of rabbit liver NAT and blood NAT indicate common structural features for 
the enzyme from these tissues (Weber et al., 1975). Recent studies of the heat 
stability and immunological characteristics of hepatic NAT from rapid and 
slow INH acetylator rabbits provide strong evidence for a structural differ- 
ence accounting for the INH acetylator polymorphism (Weber et al., 1978). 
In this report, we described a relationship between the human liver INH 
acetylator phenotype and the heat stability of lymphocyte NAT: rapid 
acetylators have a lymphocyte NAT that is less heat stable than the 
lymphocyte enzyme from a slow acetylator (Table II). In view of the 
correlation between human lymphocyte NAT and acetylator phenotype and 
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t h e  ev idence  f rom rabb i t  s tudies,  it  m a y  be an t i c ipa t ed  tha t  there  is also a 
s t r u c t u r a l  d i f ference  in h u m a n  hepa t ic  N A T  which  accoun t s  for the  I N H  
ace ty l a to r  po lymorph i sm.  F u r t h e r  s tudies  a re  necessa ry  to c lar i fy  the  rela-  
t i onsh ip  be tween  l ymphocy te  N A T  a n d  the  hepa t ic  enzyme .  
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